TL;DR: Biocartesian is a Y Combinator Summer 2024 startup Converting biology into digital molecular maps, currently active with a team of 2.
Converting biology into digital molecular maps
Last verified:
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Built by LemStudio
Yes. Biocartesian was funded by Y Combinator in the Summer 2024 batch. Converting biology into digital molecular maps
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Biocartesian was part of Y Combinator's Summer 2024 batch.
Biocartesian has a team of 2 people according to Y Combinator's directory.
Biocartesian is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…